Neuroone Medical Technologies Corp revenue
Neuroone Medical Technologies Corp's revenue was $9.1m in fiscal 2025, up 163.5% on the year before. Since fiscal 2011 ($1,167) it has grown at a compound 125.8% a year. Over the last twelve months it was $9.5m.
Revenue history
| Fiscal year | 2011Dec 2010 | 2012Dec 2011 | 2013Dec 2012 | 2014Dec 2013 | 2015Dec 2014 | 2016Dec 2015 | 2017Dec 2016 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 5 | 1 | 1 | 1 | 0 | 0 | 178 | 171 | 1,952 | 3,453 | 9,098 | 9,469 |
| Growth on the year before | — | +362.6% | −82.9% | +35.6% | −38.1% | −100.0% | — | — | −3.9% | +>999% | +76.9% | +163.5% | — |
| Gross profit | 1 | 3 | 1 | 1 | — | — | — | −98 | −71 | 457 | 1,080 | 5,141 | 5,269 |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 272 | 3,274 | 1,387 | 1,696 | 2,741 | 2,893 | 1,862 | 1,973 |
| Growth on the same quarter a year before | — | — | — | — | +906.6% | −11.7% | +34.3% | +16.3% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Neuroone Medical Technologies Corp | $9.5m | 42.8% | 94.9% |
| Milestone Scientific Inc. | $9.4m | 3.7% | -1.9% |
| Work Medical Technology Group LTD | $9.8m | -14.4% | — |
| Nuwellis, Inc. | $9.0m | 8.4% | 2.8% |
| Anbio Biotechnology | $8.6m | 5.6% | — |
| Inspiremd, Inc. | $10.8m | 53.4% | 26.6% |
Compare with peers
- Milestone Scientific Inc. revenue
- Work Medical Technology Group LTD revenue
- Nuwellis, Inc. revenue
- Anbio Biotechnology revenue
- Inspiremd, Inc. revenue
Head to head: MLSS vs NMTCNMTC vs WOKNMTC vs NUWENMTC vs NNNN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies